Roche buys US biotech firm for 5bn

Home › Roche buys US biotech firm for 5bn

Swiss pharmaceutical giant Roche says it will buy maker of lung disease therapies InterMune for $8.3bn.

27.11	Interra adds Netflix VMAF video quality assessment support
27.11	Brightcove to be acquired by Bending Spoons
27.11	FOX, Disney capitalize on multiplatform TV footprint in October
27.11	Tele Columbus TV households down 40% YoY in 3Q 2024
27.11	'It's going to be hard': US firms race to get ahead of Trump tariffs
27.11	Loyalty cards offer genuine savings, says watchdog
27.11	Aston Martin issues second profit warning in two months
27.11	Online slots gambling to be limited to 5 per spin
Consumer Goods and Services »

je.st